Stock Market Today: Small-cap pharma stock — Fredun Pharmaceuticals — edged higher during the intraday trade on Thursday despite the stock market sell-off, as investors cheered the company’s Q1 results announcement.
Fredun Pharmaceuticals Q1 results
Fredun Pharmaceuticals, a pharmaceutical formulation manufacturing company in India, reported its Q1 performance today, wherein it posted a net profit of ₹6.77 crore during the quarter ended June 2025, which was 63.82% higher compared to ₹4.13 crore in the year-ago quarter.
As per its disclosed unaudited financials for the first quarter of fiscal year 2025-26 (FY26), the revenue came in at ₹119.86 crore, a growth of 52.08% compared to ₹78.81 crore posted in the year-ago quarter.
The boost to the bottom line was further provided by the improved operating performance. The earnings before interest, tax, depreciation, and amortisation, or EBITDA, grew 62.15% to ₹16.99 crore from ₹10.48 crore in the year-ago quarter.
Fredun Medhora, Managing Director, in a statement said, “We are pleased to report a strong start to FY26 with a significant year-on-year growth in net profit and healthy improvement across all key financial metrics.”
The performance as per Medhora reflects the successful execution of our growth strategy and the continued demand for the company’s diversified portfolio across domestic and international markets.
The company’s generics portfolio continues to strengthen, with over 1,200 products currently under registration. The current order book stands at over ₹200 crore, providing strong revenue visibility and momentum for the upcoming quarters. The company is diversified into generics, cosmetics, nutraceuticals, mobility, and animal healthcare products too.
Fredun Pharmaceuticals share price movement
Small-cap stock Fredun Pharmaceuticals opened at ₹1,017 and gained further to ₹1,020 levels on Thursday, marking intraday gains of 4.73% compared to the previous day’s closing price of ₹973.95.
The gains for the small-cap stock came despite weakness in the Indian stock markets. The benchmarks — Sensex and Nifty — lost nearly 1% today.
Disclaimer: The views and recommendations made above are those of individual analysts or brokerage companies and not of Mint. We advise investors to check with certified experts before making any investment decisions.
